Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Madore DV, Meade BD, Rubin F, Deal C, Lynn F; Meeting Contributors.

Vaccine. 2010 Jun 23;28(29):4539-47. doi: 10.1016/j.vaccine.2010.04.094. Epub 2010 May 12.

2.

Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.

O'Brien KL, Moisi J, Moulton LH, Madore D, Eick A, Reid R, Weatherholtz R, Millar E, Hu D, Hackell J, Kohberger R, Siber G, Santosham M.

J Infect Dis. 2007 Jul 1;196(1):104-14. Epub 2007 May 24.

PMID:
17538890
3.

Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.

Millar EV, O'Brien KL, Bronsdon MA, Madore D, Hackell JG, Reid R, Santosham M.

Clin Infect Dis. 2007 May 1;44(9):1173-9. Epub 2007 Mar 23.

PMID:
17407035
4.

Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.

Yang DP, Zielinska E, Quiroz J, Madore D, Rappaport R.

Biologicals. 2007 Jun;35(3):183-7. Epub 2007 Jan 22.

PMID:
17241789
5.

Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide.

Giardina PC, Longworth E, Evans-Johnson RE, Bessette ML, Zhang H, Borrow R, Madore D, Fernsten P.

Clin Diagn Lab Immunol. 2005 May;12(5):586-92.

6.

Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.

Hu BT, Yu X, Jones TR, Kirch C, Harris S, Hildreth SW, Madore DV, Quataert SA.

Clin Diagn Lab Immunol. 2005 Feb;12(2):287-95.

7.
8.

Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f).

Quataert SA, Rittenhouse-Olson K, Kirch CS, Hu B, Secor S, Strong N, Madore DV.

Clin Diagn Lab Immunol. 2004 Nov;11(6):1064-9.

9.

Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine.

Huebner RE, Mbelle N, Forrest B, Madore DV, Klugman KP.

Vaccine. 2004 Jul 29;22(21-22):2696-700.

PMID:
15246599
11.

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, Benjamin W, Quataert SA, Hildreth S, Sikkema DJ, Käyhty H, Jonsdottir I, Nahm MH.

Clin Diagn Lab Immunol. 2003 Jul;10(4):514-9. Review. No abstract available.

12.

Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy.

Esposito S, Madore DV, Gironi S, Bosis S, Tosi S, Bianchi C, Cimino C, Principi N.

Vaccine. 2003 Jun 20;21(21-22):2704-7.

PMID:
12798607
13.
14.
15.

A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides.

Quataert S, Martin D, Anderson P, Giebink GS, Henrichsen J, Leinonen M, Granoff DM, Russell H, Siber G, Faden H, Barnes D, Madore DV.

Immunol Invest. 2001 Aug;30(3):191-207.

PMID:
11570640
16.

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger K, Blatter MM, Quataert SA, Madore DV, Chang I, Malinoski FJ, Hackell JG, Paradiso PR.

Pediatr Infect Dis J. 2001 Feb;20(2):153-9.

PMID:
11224833
17.
18.

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

Plikaytis BD, Goldblatt D, Frasch CE, Blondeau C, Bybel MJ, Giebink GS, Jonsdottir I, Käyhty H, Konradsen HB, Madore DV, Nahm MH, Schulman CA, Holder PF, Lezhava T, Elie CM, Carlone GM.

J Clin Microbiol. 2000 Jun;38(6):2043-50.

19.

Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus.

King JC Jr, Borkowsky W, Mahidhara N, Madore D, Shapiro ED, Rutstein RM, Tan TQ, Farley JJ, Dankner WM, Nachman S, Simoes E, Flynn PM, Clemens J, Hamilton RG.

J Infect Dis. 2000 May;181(5):1817-21. Epub 2000 May 15.

PMID:
10823792
20.

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K.

Pediatr Infect Dis J. 2000 Mar;19(3):187-95.

PMID:
10749457
21.

Use of animal testing for evaluating glycoconjugate vaccine immunogenicity.

Madore DV, Strong N, Eby R.

Dev Biol Stand. 1999;101:49-56.

PMID:
10566775
22.

Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates.

Madore DV, Johnson-Kraines CL, Rothstein EP, Smith DH.

Curr Med Res Opin. 1999;15(2):105-12.

PMID:
10494493
23.

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B, Hackell J, Paradiso PR, Siber G, Kohberger R, Madore DV, Malinowski FJ, Kimura A, Le C, Landaw I, Aguilar J, Hansen J.

Pediatr Infect Dis J. 1999 Sep;18(9):757-63.

PMID:
10493334
24.
25.
26.

Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.

Jansen WT, Gootjes J, Zelle M, Madore DV, Verhoef J, Snippe H, Verheul AF.

Clin Diagn Lab Immunol. 1998 Sep;5(5):703-10.

27.

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA, Madore DV, Chang I, Paradiso PR, Malinoski FJ, Kimura A.

Pediatrics. 1998 Apr;101(4 Pt 1):604-11.

PMID:
9521941
28.

Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model.

Kauppi-Korkeila M, van Alphen L, Madore D, Saarinen L, Käyhty H.

J Infect Dis. 1996 Dec;174(6):1337-40.

PMID:
8940229
29.

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

O'Brien KL, Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Madore D.

Pediatr Infect Dis J. 1996 May;15(5):425-30.

PMID:
8724065
30.

Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

King JC Jr, Vink PE, Farley JJ, Parks M, Smilie M, Madore D, Lichenstein R, Malinoski F.

Pediatr Infect Dis J. 1996 Mar;15(3):192-6.

PMID:
8852905
31.

Impact of immunization on Haemophilus influenzae type b disease.

Madore DV.

Infect Agents Dis. 1996 Jan;5(1):8-20. Review.

PMID:
8789595
32.

Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay.

Madore DV, Anderson P, Baxter BD, Carlone GM, Edwards KM, Hamilton RG, Holder P, Käyhty H, Phipps DC, Peeters CC, Schneerson R, Siber GR, Ward JI, Frasch CE.

Clin Diagn Lab Immunol. 1996 Jan;3(1):84-8.

33.

Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.

Quataert SA, Kirch CS, Wiedl LJ, Phipps DC, Strohmeyer S, Cimino CO, Skuse J, Madore DV.

Clin Diagn Lab Immunol. 1995 Sep;2(5):590-7.

34.
35.

A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics.

Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Johnson C, Madore D, Hogerman D.

Pediatr Infect Dis J. 1994 May;13(5):368-72.

PMID:
8072818
36.

Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants.

Paradiso PR, Hogerman DA, Madore DV, Keyserling H, King J, Reisinger KS, Blatter MM, Rothstein E, Bernstein HH, Hackell J.

Pediatrics. 1993 Dec;92(6):827-32.

PMID:
8233745
37.

Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group.

Black SB, Shinefield HR, Ray P, Lewis EM, Fireman B, Hiatt R, Madore DV, Johnson CL, Hackell JG.

Pediatr Infect Dis J. 1993 Dec;12(12):981-5.

PMID:
8108224
38.
39.

Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.

Rothstein EP, Schiller RP, Girone JA, Hipp TJ, Souder RL, Bernstein HH, Madore DV, Johnson CL, Smith DH.

Am J Dis Child. 1991 Aug;145(8):898-900.

PMID:
1858727
40.

Comparison of antigenuria after immunization with three Haemophilus influenzae type b conjugate vaccines.

Rothstein EP, Madore DV, Girone JA, Schiller RP, Hipp TJ, Souder RL, Bernstein HH.

Pediatr Infect Dis J. 1991 Apr;10(4):311-4.

PMID:
2062627
41.

An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay.

Phipps DC, West J, Eby R, Koster M, Madore DV, Quataert SA.

J Immunol Methods. 1990 Dec 31;135(1-2):121-8.

PMID:
2273252
42.

Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.

Madore DV, Johnson CL, Phipps DC, Myers MG, Eby R, Smith DH.

Pediatrics. 1990 Oct;86(4):527-34.

PMID:
2216616
43.
44.

Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants.

Madore DV, Johnson CL, Phipps DC, Popejoy LA, Eby R, Smith DH.

Pediatrics. 1990 Mar;85(3):331-7.

PMID:
2304786
45.

Haemophilus influenzae b polysaccharide revaccination: a continued role for the unconjugated vaccine.

Pichichero ME, Bracikowski A, Sullivan R, Madore D, Anderson P.

Pediatr Infect Dis J. 1989 Jan;8(1):20-3.

PMID:
2784202
46.

Haemophilus b oligosaccharide-CRM197 and other Haemophilus b conjugate vaccines: a status report.

Smith DH, Madore DV, Eby RJ, Anderson PW, Insel RA, Johnson CL.

Adv Exp Med Biol. 1989;251:65-82. Review. No abstract available.

PMID:
2692432
47.

Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.

Madore DV, Phipps DC, Eby R, Johnson CL, Smith DH.

Contrib Microbiol Immunol. 1989;10:125-50. Review. No abstract available.

PMID:
2684505
48.

Standardization of antibody assays for measuring the response to pneumococcal infection and immunization.

Siber GR, Priehs C, Madore DV.

Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S84-91. Review. No abstract available.

PMID:
2648302

Supplemental Content

Loading ...
Support Center